Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
From MaRDI portal
Publication:541886
DOI10.1016/j.mbs.2011.02.010zbMath1214.92042OpenAlexW2060065761WikidataQ51595754 ScholiaQ51595754MaRDI QIDQ541886
Publication date: 8 June 2011
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2011.02.010
Feedback control (93B52) Application models in control theory (93C95) Medical applications (general) (92C50)
Related Items (7)
Constrained bilinear control problem: Application to a cancer chemotherapy model ⋮ Periodic solutions of angiogenesis models with time lags ⋮ On dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapies ⋮ On probabilistic certification of combined cancer therapies using strongly uncertain models ⋮ A novel control set-valued approach with application to epidemic models ⋮ Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design ⋮ Optimal bounded controls problem for bilinear systems
Cites Work
- Unnamed Item
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Immunotherapy: an optimal control theory approach
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- Modeling immunotherapy of the tumor -- immune interaction
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- A hierarchy of cancer models and their mathematical challenges
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- A set-valued approach to control immunotherapy
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
- A Unified Set-Valued Approach to Control Immunotherapy
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour
- Feedback Spreading Control under Speed Constraints
- Cancer Modelling and Simulation
- Feedback Spreading Control Applied to Immunotherapy
- Target control by using feedback spreading control with application to immunotherapy
- Set-valued analysis
- Viability theory
- Simple ODE models of tumor growth and anti-angiogenic or radiation treatment
This page was built for publication: Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
